Abata Therapeutics

$7.2M revenue • 40 employees • United States

Last Updated May 8, 2025

Company Overview

Company Name

Abata Therapeutics

Address

United States

Approx. Annual Revenue

$7.2M

Employees

40

Established

2021

About Abata Therapeutics

Abata Therapeutics is a US-based biopharmaceutical company developing transformative therapies for autoimmune diseases. The company's targeted, autologous regulatory T-cell (Treg) therapies aim to stop immune-mediated destruction, restore homeostasis, and promote tissue repair in conditions like progressive multiple sclerosis and type 1 diabetes.

Business Profile

Read from the Abata Therapeutics website on Oct 14, 2026. Hover an item to see the exact wording it came from.

About the website

Website quality (AI-assessed)
8/10 · Current pipeline and news; Clear navigation and contact

Biotech & Life Sciences Companies near CA

Browse all Biotech & Life Sciences companies in California →

Frequently Asked Questions about Abata Therapeutics

Categories

Social Profiles

Key Decision Makers

Samantha Singer President
LinkedIn
Alison Occhiuti Kroell Director Clinical Development Operations
LinkedIn